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Abstract
One-half of the integrin a-subunit Propeller domains contain and extra vWFA domain (aA domain), which mediates integrin
binding to extracellular physiologic ligands via its metal-ion-dependent adhesion site (MIDAS). We used electron
microscopy to determine the 3D structure of the aA-containing ectodomain of the leukocyte integrin CD11b/CD18 (aMb2)
in its inactive state. A well defined density for aA was observed within a bent ectodomain conformation, while the structure
of the ectodomain in complex with the Fab fragment of mAb107, which binds at the MIDAS face of CD11b and stabilizes the
inactive state, further revealed that aA is restricted to a relatively small range of orientations relative to the Propeller
domain. Using Fab 107 as probe in fluorescent lifetime imaging microscopy (FLIM) revealed that aA is positioned relatively
far from the membrane surface in the inactive state, and a systematic orientation search revealed that the MIDAS face would
be accessible to extracellular ligand in the inactive state of the full-length cellular integrin. These studies are the first to
define the 3D EM structure of an aA-containing integrin ectodomain and to position the ligand-binding face of aA domain
in relation to the plasma membrane, providing new insights into current models of integrin activation.
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Introduction
Integrins are non-covalent ab heterodimeric cell adhesion
receptors that regulate diverse biological processes by signaling
bidirectionally across the plasma membrane (reviewed in [1]).
Crystal structure of aVb3 [2] and aIIbb3 ectodomains [3]
revealed that integrins adopt a compact bent conformation that
consists of a ligand-binding ‘head’ comprising a seven-bladed
Propeller domain from the a-subunit bound noncovalently to a
vWFA domain (bA domain) from the b-subunit. The Propeller
domain is followed by a Thigh- and Calf-1 and Calf-2 domains, a
transmembrane (TM) segment ending with a short cytoplasmic
tail. bA is inserted in an Ig-like Hybrid domain, which is flanked
by an N-terminal PSI domain and followed by four EGF-like
domains (EGF1-4), a beta-tail domain (bTD), a TM segment and
terminating with a short cytoplasmic tail. Bending in the structure
occurs at two knees (genu) (located between the Thigh and Calf-1
domains of the a-subunit and in EGF2 of the b-subunit [4]). Mg
2+-
dependent binding of physiologic ligands takes place at the
integrin head, and requires a metal-ion-dependent-adhesion-site
(MIDAS) in the bA domain [5]. In nine of the twenty-four
mammalian integrins, an additional vWFA domain (aA domain) is
inserted in the Propeller domain, and acts through its MIDAS face
as the principal ligand-binding site [6].
The aA-containing leukocyte integrin CD11b/CD18 (aMb2) is
the major integrin expressed in phagocytic cells, and plays a vital
role in host defense by mediating the extravasation of phagocytic
cells to inflamed organs and the phagocytosis of serum-opsonized
pathogens [7]. Like most integrins, CD11b/CD18 is normally
expressed on the cell surface in an inactive conformation, thus
allowing leukocytes to circulate in the blood stream and preventing
pathologic inflammation. Previous studies in other integrins have
elucidated an essential role for hydrophobic and electrostatic
interactions between the a- and the b-subunit TM/cytoplasmic
tails (reviewed in [8]) in stabilizing the inactive state. These
interactions have been mimicked experimentally by placing an
artificial inter-subunit disulphide in the membrane proximal a/b
linker regions of the ectodomain [4,9,10]. In response to activation
signals, the cytoskeletal protein talin disrupts the integrin
cytoplasmic a/b interaction [11], inducing an allosteric rear-
rangement that shifts the conformational equilibrium of the
ectodomain in favor of the ligand-binding state, a process that may
also require kindlins [12]. The crystal structure of the isolated aA
domain (CD11bA) from integrin CD11b/CD18 has been
determined in its inactive [13] and ligand-occupied states [14],
distinguished by local structural changes that modulate the ligand-
binding competency of MIDAS. Ligand-bound aA acts as an
intrinsic ligand for the bA domain [15], triggering the conforma-
tional changes that lead to outside-in cell signaling. Crystal
structure of CD11bA in complex with the ligand-mimetic Fab
fragment of mAb107, a Ca
2+-mediated interaction that stabilizes
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[16], opening new venues for modulating the functional activity of
this integrin. However, no information on the 3D structure of the
CD11b/CD18 ectodomain or the position of its CD11bA relative
to the cell membrane is available to date. A crystal structure of a
related CD11c/CD18 ectodomain in its bent inactive conforma-
tion has been recently reported [17]. Since only two out of ten
molecules in that structure were defined, it was concluded that the
aA domain is very flexible within the integrin head.
In this communication, we used electron microscopy and 3D
image reconstruction to determine the 3D structure of inactive
CD11b/CD18 ectodomain as well as its EM structure bound to
the Fab 107. Surprisingly, we find that CD11bA is restricted to a
relatively small range of positions within a bent ectodomain
conformation in the 3D EM structure. Using high-resolution
fluorescent lifetime imaging microscopy (FLIM) in full length
CD11b/CD18, we show that CD11bA is positioned well beyond
the membrane surface in the inactive state, while a systematic
orientation search defines a specific tilt angle between the
ectodomain and TM domains, which would allow access of the
inactive integrin to soluble ligand. The significance of these
findings in relation to current models of integrin activation is
discussed.
Materials and Methods
Reagents and antibodies
Restriction and modification enzymes were obtained from New
England Biolabs Inc. (Beverly, MA). The cell culture reagents were
purchased from Invitrogen Corp (San Diego, CA) or Fisher
Scientific (Hampton, NH). The b2 integrin heterodimer-specific
murine mAb IB4 [18] and the ligand-mimetic mAb107 [19] have
been previously described. The fluorescent labeling reagents
Alexa-488 NHS ester and FM 4-64FX were from Invitrogen
Corp. The Fab-fragment (Fab107) of mAb 107 IgG was prepared
by papain digestion followed by affinity chromatography as
described [16]. Fab107 was labeled with Alexa Fluor 488 N-
hydroxy succinimidyl ester (NHS) dye using the manufacturer’s
recommended protocol and excess dye was removed using Centri-
Spin 20 size-exclusion microcentrifuge columns (Princeton Sepa-
rations, Adelphia, NJ).
Cell culture and transfection
Stable transfection of wild-type (WT) CD11b/CD18 or the
same integrin containing the activating I316G mutation in
CD11bA [16] was carried out in K562 cells (from American
Type Culture Collection, Manassas, VA) using published protocols
as previously described [20]. Transformed cells were maintained
in IMDM supplemented with 10% heat-inactivated fetal bovine
serum, 100 IU/ml penicillin, 100 mg/ml streptomycin and
0.5 mg/ml G418.
Flow cytometry
Harvested K562 were washed in Hepes-buffered saline (50 mM
Hepes, 150 mM NaCl, pH 7.4) containing 0.1% BSA (washing
buffer, WB), incubated in 10 mM EDTA in WB for 5 min at room
temperature, then washed in WB three times. 1610
6 cells were
suspended in 100 ml WB containing either 1 mM CaCl2 or 5 mM
MgCl2/1mM EGTA (which converts b2 integrins into ligand-
competency [21]) for 10 min at 37uC, then stained with mAbs 107
or IB4 (each at 20 mg/ml, for 30 min at 37uC). After washing with
the respective metal ion-containing buffer, cells were incubated
with allophycocianin-conjugated goat anti-mouse Fc specific
antibody (Jackson) at 1:30 dilution in the dark at 4uC for another
30 min. Washed cells were resuspended in 400 ml of the respective
metal ion-containing buffer, fixed in 2% paraformaldehyde and
analyzed by flow cytometry in a FACSCalibur flow cytometer (BD
Biosciences) counting 20,000 events. Mean fluorescence intensity
(MFI) was determined using the CellQuest software (BD) and
binding of mAb 107 was expressed as a percentage of mAb IB4
binding.
Expression and purification of CD11b/CD18 ectodomain
Cloned cDNA encoding human CD11b ectodomain (residues
F1-N1088) and containing the I316G substitution in CD11bA
were fused in-frame and upstream to a cDNA sequence encoding
a single cysteine residue (replacing P1089 in CD11b) that is
followed by a PreScission protease site, an Acid coiled-coil motif
and a 6-Histidine tag. cDNA encoding human CD18 ectodomain
(residues Q1-N678) was similarly inserted into a cDNA sequence
encoding a single cysteine residue (replacing I679 in CD18), a
PreScission protease site and a Basic coiled-coil motif. Both
constructs were cloned into a pCF expression vector. The resulting
positive clones were used to transfect glycosylation-deficient CHO
Lec 3.2.8.1 cells (kindly provided by Dr. Pamela Stanley, Albert
Einstein College of Medicine, NY)[22] using Lipofectamine 2000,
to make stable cell lines under double selections (G418 and
Hygromycin). Protein expression was monitored using ELISA, in
which mAb IB4 was used as the catch antibody, and anti-His
antibody as the secondary antibody. The clones giving the highest
expression level were kept for protein production in triple layer
flask. Secreted protein was first purified on Ni-NTA affinity
column, then using mAb107 affinity column. After cleavage of
both ACID-BASE coiled-coil motifs and His-tag, the digested
protein was further purified on Superdex 200 10/30 HR size-
exclusion column. A yield of purified heterodimeric protein of
,0.5 mg/L of cell culture was obtained. SDS-PAGE analysis
under non-reducing conditions revealed a single Coomassie-
stained band corresponding to the disulphide-linked heterodimer,
which converted to two bands corresponding to the CD11b and
CD18 subunits under reducing conditions (not shown).
Electron microscopy and image analysis
Aliquots (,5 ml) were allowed to adhere for ,30 sec to carbon-
coated copper grids that had been rendered hydrophilic by glow
discharge in air and then stained with 0.75% uranyl formate
(Electron Microscopy Sciences, Hatfield PA). Images were
recorded under minimum electron dose conditions using a
CM100 electron microscope (Philips Electron Optics/FEI,
Eindhoven, The Netherlands). Images were recorded on Kodak
SO163 film at a nominal magnification of 35,000 for CD11b/
CD18 ectodomain or 46,000 for the integrin/Fab107 complex,
using 100 kV electrons. Micrographs were digitized with a Super
Coolscan9000 ED scanner (Nikon, Inc.) at 8 bits per pixel and
6.35 mm per pixel, subsequently averaged to 12.7 mbm per pixel.
The optical density for each negative was adjusted to give a mean
value of ,127 over the total range of 0 to 255. Image processing
was performed with the EMAN suite. For the CD11b/CD18
ectodomain, an automated, model-free particle selection routine
implemented in the EMAN program boxer was used to select a total
of 8,825 particles from 12 negatives. CTF parameters for each
negative were determined with the EMAN program ctfit and phase
corrections performed for each particle. Reference-free class
averages were generated with the routine startnrclasses, followed
by seven rounds of reclassification using the projection matching
routine classesbymra, as implemented in the script refine2d.py. 3D
refinements were performed with the EMAN routine refine using a
10u angular spacing for model projections. Initial models were
Structure of Leukocyte Integrin CD11b/CD18
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refinements was monitored by examining the Fourier shell
correlation between successive models during the refinement and
halted when the 50% correlation position failed to show any
improvement. Estimation of the resolution of final models was
performed by examination of the Fourier shell correlation between
models produced by separating the raw particles into two groups
and calculating separated 3D maps from each group using the
classification generated from the final round of refinement. For the
integrin/Fab107 images, the same methods were used to select
10,661 from 20 negatives. Reference-free class averages were
generated from the CTF corrected particle set identically as with
the CD11b/CD18 data set.
FLIM Assays
Wells of non-fluorescent Labtek II four-chamber microscope
slides (Nalgen Nunc, Rochester, NY) were coated with poly-L-
lysine (Sigma-Aldrich St. Louis, MO) overnight at 4uC. CD11b/
CD18 K562 cells (25,000–50,000) were transferred in Tris-
buffered saline, pH 7.4 (TBS) to each well and incubated for
one hour at 37uC in a total volume of 200 mL. Non-specific sites
were then blocked by incubation with TBS containing 1% Bovine
Serum Albumin (Sigma-Aldrich) for 30–60 min at 37uC. The wells
were washed twice with TBS to remove non-adherent cells. The
remaining cells were preincubated in TBS containing 1 mM Ca
2+
(TBS
+) for 15 min at 37uC. For immunolabeling, adherent live
K562 cells stably expressing CD11b/CD18 were stained with
20 mg/ml Fab107-Alexa488 in TBS
+ for 30 min at 4uC. After
washing twice with TBS
+, and once in Hank’s Balanced Salt
Solution containing 1 mM Ca
2+ (HBSS
+, Invitrogen), Fab107-
Alexa488- labeled cells were incubated in the absence or presence
of 6–12 mM FM solution in HBSS
+ for 10 min at 4uC, washed in
HBSS
+, then fixed with ice-cold 4% paraformaldehyde in PBS for
10 min at 4uC, washed with ice-cold PBS and mounted with GVA
mount (Invitrogen) under a cover slip. The GVA-mounted slides
were kept overnight in the dark at room temperature to set the
mounting media and used the next day in FLIM assays.
FLIM assays were performed as previously described [4].
Briefly, a mode-locked Ti-sapphire laser (Spectra-Physics, Fre-
mont, CA), which sends a femto-second pulse every 12 nsec to
excite the fluorophore at 800 nm, was used for all assays. Images
were acquired using a Bio-Rad Radiance 2000 multi-photon
microscope (Hercules, CA). A high-speed photon detector (MCP
R3809, Hamamatsu, Bridge water, NJ) coupled to time-correlated
single photon counting SPC830 hardware and SPCImage software
from Becker and Hickl (Berlin, Germany) was used to measure
fluorescence lifetimes on a pixel-by-pixel basis. This set-up allows
high temporal resolution lifetime acquisition with high spatial
resolution imaging. Laser power was kept fixed at 2%. Data from
individual cells was collected in each condition. A 1286128 pixel
matrix was created with the single exponential (for donor alone) or
multi-exponential (donor in the presence of acceptor) curve-fit
data for each pixel, allowing color-coding by lifetime over the
entire image. As a negative control, Alexa488 lifetime was
measured in the absence of the acceptor (donor only). Percent
lifetime decrease, or FRET efficiency, E, was calculated as the
difference between excited state of the donor in absence (tD) and
in presence (tDA) of acceptor fluorophore, or: E=12tDA/tD. The
distance between donor and acceptor fluorophores, r, was
calculated using the following equation [23]: r=R0 (tD/tDA
21)
21/6, where R0 is the Fo ¨rster radius, or the distance at which
energy transfer is 50%. Here, we used a value of 62A ˚, estimated
based on the Forster radius of Alexa Fluor 488 with Alexa Fluor
568 as acceptor (Invitrogen website).
Orientation Modeling
The structure of the CD11b/CD18 in complex with Fab107
was derived from the reference-free class averages from EM
images of the complex by sequentially determining the orientation
of the integrin ectodomain (without CD11bA) for each average
followed by the determination of the CD11bA/Fab107 orienta-
tion. An electron density map from the aVb3 ectodomain filtered
to 18A ˚ resolution was generated with the EMAN routine pdb2mrc
and 2D projections generated at 8u intervals with project3d. The
projections were searched against the class averages with the
EMAN program classesbymra2 to determine the W and H Euler
angles. The remaining parameters (x and y shifts, Euler angle v)
were determined by a cross-correlation search of the reference
projection with the class average. The aligned reference projection
was subtracted from the class average and the resulting difference
map classified against a set of reference projections prepared from
the CD11bA/Fab107 structure. Additional models were generated
with the CD11c/CD18 ectodomain X-ray structure (pdb id
3K71), using chains G and H that possess the aA domain density.
Homology modeling between the two aA domains was used to
place Fab107 on the CD11c/CD18 structure. To generate a
canonical ‘bent model’, crystal structure of inactive aVb3
ectodomain (pdb 1jv2) was superimposed on that of CD11c/
CD18 ectodomain by homology modeling between the a-chain
Propeller domain while the Fab107/CD11bA structure was
superimposed on CD11c/CD18 as before. The final model was
generated by deleting the CD11c/CD18 chains leaving the
oriented aVb3 ectodomain/Fab107 CD11bA chains. Each of
the models was oriented to a common origin by a series of rigid
body rotations and translations. A vector to define the Calf1/Calf2
domains was chosen by setting one end point to the center of the
disulfide bond defining the large loop at the end of Calf-1 (C755
and C761 in CD11c; C596 and C602 in aV) and the other end
point as the last residue in a-subunit (P1090 in CD11c; W953 in
aV). The last residue in the a-subunit was translated to coordinate
0,0,0 in space and the model rotated to position the vector
vertically (x=y=0). To systematically generate different orienta-
tions, the models were first rotated about the z axis (angle W), then
rotated around the y axis (angle H). To determine clashes with the
membrane the coordinates of each atom were compared with an
x-y plane representing the membrane. The z-coordinate of the
plane was positioned at the start of the transmembrane helix, and
the distance between the helix start and the last residue in the a-
chain used the previously determined model of the intervening
residues in aV [4]. Due to the random labeling of Fab 107 and the
large number of individual Fab molecules on the cell, the average
distance is given by the centroid for the fluorophores. To derive a
single point to represent the Fab, the centroid between the a-
carbons of all of the lysine residues in the in the Fab107 X-ray
structure [16] was therefore used as previously described [4].
Results
Electron microscopy analysis indicates that the isolated
CD11b/CD18 ectodomain is in a bent conformation
We determined the 3D EM structure of CD11b/CD18
ectodomain in buffer containing the inhibitory Ca
2+ [24], which
stabilizes the inactive state. The full dataset contained 8,825
particles selected from negatively stained micrographs using an
automated, model-free algorithm. Preliminary analysis was con-
ducted with reference-free alignment and classification, where raw
particle images are aligned to a common center and classified
using features extracted from the covariance of the global average.
This method, which does not rely on any presupposition of the
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PLOS ONE | www.plosone.org 3 February 2013 | Volume 8 | Issue 2 | e57951protein’s structure, produced several averages, which closely
resemble views expected from a bent conformation of the
ectodomain (Figure 1). Indeed, all of the resulting averages were
compact, and the majority could be assigned to a bent
conformation. Side views displayed clear density for CD11bA
domain, indicating that in CD11b this domain is relatively stable,
as conformational flexibility would have led to its density being
averaged out.
3D image analysis and reconstruction bore out the bent
conformation for the CD11b/CD18 ectodomain. The 3D analysis
was performed using the full dataset (8,825 particles) employing a
projection-matching algorithm implemented in EMAN. The
model generated in the final round included 7,587 particles from
the data set. The remaining particles were rejected by the
algorithm as a result of statistical tests during the refinement. The
rejected particles may represent CD11b/CD18 in alternate
conformations, denatured protein, poorly stained particles or
contain only background. The resulting 3D structure closely
resembles a low-resolution structure calculated from the aVb3
ectodomain [25] (with an added aA domain), rather than the
related CD11c/CD18 ectodomain crystal structure [17]. Results
from the final reconstruction are shown in Figure 1. Although each
of the 181 projection classes contained particles, the raw particles
did show a preferential orientation for only a few Euler angles
(Figure 1B). These views showed the integrin ectodomain in a
characteristic side view, with a clear ‘V’ shape formed by the angle
between the Thigh domain and the Calf-1/Calf-2 domains, or
rotated by 90u such that the CD11b Propeller and Thigh domains
are facing the viewer (Figure 1A, a, b). This model rapidly
converged, and after the sixth round subsequent rounds of
refinement did not substantially change the structure or improve
resolution. Resulting averages and projections from some of the
classes in the final round are shown in Figure 1A. As can be seen,
the final class averages closely resemble the map projections. Also
shown are example raw particles to demonstrate the agreement
between particles and the averages, and some of the reference-free
averages, which were calculated without any model input. The
reference-free averages have been placed near the final class
average that they most closely resemble. The final map faithfully
represents the protein conformation as found in the dataset, and is
not the result of model bias. The final resolution of the map as
determined by Fourier shell correlation is ,26A ˚ using the 50%
cutoff criterion (Figure 1C).
The resulting map from the final round of refinement is shown
in Figure 2A–D. The map has been filtered to 26A ˚, and the
isosurface set to enclose 100% of the expected protein volume.
Excluding the density attributable to the CD11bA domain, the
map resembles the canonical ‘bent’ conformation as seen in the
aVb3 ectodomain structure [25]. The map density does not fit
well the X-ray structure for CD11c/CD18 ectodomain (Figure 2E,
F): While the head, Thigh and Hybrid domains fit well into the
map density, Calf-1/Calf-2 clearly lie outside it (Figure 2E, F).
Both ectodomains contain an engineered interchain disulfide bond
at the identical position in the membrane-proximal a/b linker
region of the ectodomain, so the difference is more likely the result
of crystal contacts among the four molecules in the unit cell of
CD11c/CD18 ectodomain distorting these domains from their
position in solution. The aA domain from the CD11c structure fits
better within the map density but extends somewhat outside it
(Figure 2E, F), requiring a small 5A ˚ translation from its position in
the CD11c X-ray structure [17].
Determination of the relative orientation of the MIDAS
face of CD11bA domain in the integrin ectodomain
Because of the low resolution of our 3D EM map and the
generally spherical nature of aA domain, we sought to indepen-
dently assess its orientation relative to the Propeller domain by
further examining the EM structure of a complex formed between
the CD11b/CD18 ectodomain and Fab 107, a ligand mimetic
that binds at the MIDAS face and stabilizes the integrin in the
inactive state in the presence of the inhibitory Ca
2+ [16](Figure
S1). The Fab fragment binds by an extensive and well-defined
interface and thus allows identification of the CD11bA MIDAS
face even at low resolution. Class averages generated from these
particles (Figure 3A) closely resemble the averages generated from
the ectodomain on its own, with the exception of a bilobed density
attributable to the Fab. This indicates that the ectodomain within
the complex is also in the bent conformation and that the Fab does
not seem to interfere with the preferential orientation of the
integrin on the grid. The presence of well-defined Fab density
indicates that CD11bA/Fab107 complex possesses a limited range
of orientations within the integrin, as a highly flexible link between
CD11bA and the Propeller would result in the density for the
former being averaged out. Attempts to generate a 3D map from
the raw particles failed, with the resulting map not being
interpretable as either integrin or Fab density. While this may
Figure 1. EM refinement of the CD11b/CD18 ectodomain. (A)
Example images from the final round of refinement. On the left is an
average image generated from reference-free alignment and averaging
which preceded the refinement itself. The averages have been
displayed with the final map projection that they most closely
resemble. Results from the final round of refinement are displayed
adjacent to the reference-free average, showing from left to right of
each panel the average from reference free alignment (number 1), an
example raw particle from the final projection class (number 2), the
average generated from the final projection class (number 3), and the
projection from the final map for this class (number 4). The letters on
the left indicate the class in the distribution histogram (B). The side of
each box is 232A ˚. (B) Projection histogram showing the number of
particles identified as belonging to a particular Euler angle orientation
for the final round of refinement. Each circle indicates a particular class
while the number of particles is indicated as a gray scale. The scale bar
is indicated to the right. The letters refer to the classes shown in (A). (C)
Fourier shell correlation analysis to determine the resolution of the final
map. The total dataset was separated randomly into two equal groups.
The particle classes for each group were independently aligned with
the final map projection and averaged to generate two independent
maps. The graph displays the correlation in Fourier space between the
maps. The resolution of 1/(26 A ˚) is determined by a value of 50%
correlation.
doi:10.1371/journal.pone.0057951.g001
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this unlikely due to the close correspondence between class
averages generated from complexed and non-complexed particles.
We rather attribute the different results for the two datasets to the
different sizes of the masks used during the course of the
reconstruction algorithm. The presence of the Fab required the
use of a much larger mask than was needed for CD11b/CD18
ectodomain on its own to include all of the protein density. This
necessarily included a larger area of the graphite background
during the reconstruction, which combined with the low signal-to-
noise ratio for these particles to defeat the 3D reconstruction
algorithm. In support, a very tightly masked reconstruction of the
ectodomain/Fab107 particles, which cuts off the Fab density
resembles the map generated from CD11b/CD18 alone (not
shown).
The presence of well-defined density attributable to both
integrin ectodomain and Fab107 allowed us to determine the
relative orientation by matching projections for both elements. We
identified the relative angle for the integrin ectodomain by finding
the best match between the class average and a set of projections of
the integrin ectodomain, and the relative angle for the CD11bA/
Fab107 complex found with the same method. Thus, for each class
average, a model may be constructed by combining the underlying
atomic structures with the identified orientations. We fit the
CD11bA domain separately from the remainder of the integrin
Figure 2. Surface shaded density of the final 3D map of the
CD11b/CD18 ectodomain. A, B) are two views of the map rotated by
45u. The isosurface has been chosen to enclose 100% of the expected
protein volume. C and D) the same views of the map as in A and B,
shown as a transparent isosurface, but also displaying the aA-lacking
aVb3 ectodomain (pdb 3IJE) model as a ribbon diagram. A clear density
corresponding to the CD11bA domain is seen, fitted here with a ribbon
diagram of the crystal structure of the isolated CD11bA (pdb 1jlm), with
the MIDAS ion in cyan. The aV subunit and CD11bA are shown in blue
and b3-subunit in red. The spherical metal ions in the Propeller and a-
genu are in green and that in the bA ADMIDAS is in magenta. E, F) a
ribbon diagram of the crystal structure of CD11c/CD18 ectodomain
fitted into the CD11b/CD18 EM map (shown as a transparent
isosurface). Most of Calf-1/Calf-2 and b TD domains do not fit the 3D
map. CD11cA fits better within the map density but extends somewhat
outside it (compare CD11cA with that of CD11bA [shown in yellow,
oriented as in C, with its MIDAS metal ion in orange]). The three metal
ions in the CD11c Propeller are in green, the CD11cA MIDAS ion in cyan,
and the bA ADMIDAS ion in magenta. F) a 45u clockwise rotation of the
Figure in (E).
doi:10.1371/journal.pone.0057951.g002
Figure 3. EM analysis of the CD11b/CD18-Fab107 complex and
orientation of the CD11bA MIDAS face. (A) Reference-free
alignment and averaging of CD11b/CD18-Fab107 particles. The top
row shows a k-means classification of 10,661 raw particles classified into
10 groups and averaged. The number of particles for each class is
indicated at the top of each average. Several of the groups are similar,
suggesting that there are fewer than 10 unique preferred orientations
for the particles on the grid. The bottom row shows the model
projection that best fits each of the particles shown in the top row.
Projections in the bottom row were generated from the model shown
in (B) which was generated by sequentially fitting a projection for the
integrin followed by the projection for the CD11bA/Fab107 complex.
For comparison, the model generated by fitting the CD11c/CD18
ectodomain X-ray structure is shown in (C). In this model, the CD11bA
domain has the same relative orientation to the rest of the integrin as
found in the X-ray structure. (D) Shows a direct comparison of the two
models for the average, which most easily allows identification of
individual integrin domains within the projection. Displayed alongside
the average (center image) is the projection from the model in (B)
which best fits the average (left image), compared to the projection
from the model in (C) (right image). E, ribbon diagram of the Propeller/
aA of CD11c/CD18 ectodomain crystal structure oriented as in Figure 2E,
showing crystal contacts from two symmetry-related molecules (Calf-2
in gray and Thigh in magenta) that rotate MIDAS face of CD11cA
domain by ,35u (red arrows) relative to its position in the unrestricted
EM model (colored as in Figure 2E). F, same Figure in (E) rotated
clockwise by 135u.
doi:10.1371/journal.pone.0057951.g003
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which suggested that the connection between aA and the Propeller
domains would be flexible [17]. The models generated from fitting
the class averages are closely similar, and any one of them fits with
all of the class averages (Figure 3A), suggesting that CD11bA is
restricted to a relatively small range of orientations. The pseudo
atomic model derived from EM image analysis (Figure 3B) places
CD11bA in a similar location to its position in the model derived
from fitting the CD11bA/Fab107 structure into the CD11c/
CD18 X-ray structure (Figure 3C). However, an ,35u rotation of
CD11bA from its position in the latter model is sufficient to fit the
data derived from the EM structure of the ectodomain alone. The
need for this combined movement is illustrated in Figure 3D,
which shows a reference-free class average (center image) in
comparison with the calculated projection that best fits the average
from the EM model on the left, with the best fitting projection
from the CD11c/CD18-derived model on the right. The rotation
changes the orientation of the Fab, providing distinct, highly
characteristic views, and significantly improves the cross correla-
tion coefficient between the model and the class average from 0.79
(in the CD11c/CD18 structure derived model) to 0.88 (in the
CD11b/CD18 EM-derived model). The ,35u rotation of aA
domain in the CD11c/CD18 ectodomain crystal structure vs. the
EM structure is likely the result of unfavorable crystal contacts
from two symmetry-related molecules (Figure 3E, F).
Fab 107 defines orientation of CD11bA MIDAS face
relative to the plasma membrane in inactive cellular
CD11b/CD18
Since mAb107 binds the MIDAS face in the presence of the
inhibitory Ca
2+ [16,19], it provides an ideal structurally defined
FLIM probe to site-specifically label the MIDAS face to evaluate
its orientation relative to the plasma membrane in inactive
CD11b/CD18 in live cells. FLIM measures the fluorescence
lifetime of only the donor fluorophore, is relatively insensitive to
variations in donor and acceptor fluorophore concentration and
optical pathlength and has picosecond resolution, making it ideal
for quantitatively determining proximity of two fluorophores. The
efficiency of fluorescence resonance energy transfer (FRET)
between the donor–acceptor fluorophore pair is quantitatively
described by the Fo ¨rster equation, where the efficiency of transfer
E=R 0
6/(R0
6+R
6), such that there is no appreciable FRET
between the pair (and consequently no reduction in donor
fluorescence lifetime) at a separation distance of.,2R0 between
the donor and the acceptor fluorophores, where R0 is a constant
depending on the spectral properties and the relative orientation of
the two fluorophores [26,27]. In the FLIM experiments, we used
Fab 107 to obtain information about proximity and orientation of
CD11bA relative to the cell membrane with higher confidence
and accuracy. Fab 107 was chemically fluorescently labeled using
’donor’ Alexa488 NHS ester to generate Fab107-Alexa488. We
labeled the Fab107 to various degrees with Alexa488 and
determined that the post-labeling Fab107:Alexa 488 ratio of
,1:3 provided optimum signal-to-noise ratios in FLIM experi-
ments (data not shown). For selective labeling of the cell
membrane with an ‘acceptor’ fluorophore, we chose FM 4-64
FX dye (FM), which rapidly and preferentially inserts into the
outer leaflet of a cell membrane, and can be rapidly fixed,
minimizing diffusion on the FLIM measurement timescale and
structurally defining position of the acceptor.
K562 cells stably expressing the recombinant integrin were
stained with 20 mg/ml Fab107-Alexa488 at 4uC in a buffer
containing 1 mM Ca
2+ (Figure 4A, B). FLIM measurement in the
absence of FM acceptor fluorophore produced a broad range of
lifetimes of between 1,651 and 2,513 ps (Figure 4B). When these
lifetimes were fit to a Gaussian distribution they were found to
possess a mean of 2,234613 ps (695% confidence limits) with a
standard deviation of 88613 ps. This is similar to the 2,384 ps
lifetime of unbound Fab-Alexa488 (not shown), suggesting that the
Fab107-Alexa488 labeled cells are devoid of any endogenous
fluorescence acceptor and are fully exposed to the solvent and not
interacting with the protein, which might lengthen the lifetime.
Solvent exposure indicates that the fluorophores, attached to the e-
amino group of the lysines, are able to tumble freely in solution
and thus be randomly oriented. Only a minor population of cells
seems to be intrinsically quenched. When the Fab107-Alexa488-
labeled cells were further labeled with the membrane dye FM as
an acceptor fluorophore, the Alexa488 fluorescence lifetime
decreased significantly, generating a range of lifetimes between
1,354 and 2,099 ps. These lifetimes may also be fit to a single
Gaussian with a mean of 1,529614 ps and a standard deviation of
115614 ps (Figure 4B). There is also a minor population of cells
with lifetimes falling outside the fitted distribution, although in this
case with longer lifetimes than the mean. In both cases the whole
cell lifetimes may be fit to single Gaussian, with correlation
coefficients of 0.83 and 0.88 for the quenched and unquenched
measurements, respectively. Taking the mean values for the fits to
the two datasets yields a FRET efficiency of ,32% and a mean
donor-acceptor separation distance (R) of ,71A ˚, using the R0(2/3)
value of 62A ˚ for this donor-acceptor pair. Using the standard error
of the mean produces an error estimate of only6,1A ˚. Using61s
for each of the fitted distributions produces a range of possible R
values of between 76A ˚ and 67A ˚. This result suggests that in the
inactive conformation, the MIDAS face of CD11bA in full-length
receptor lies in proximity to the cell’s lipid bilayer, but not
immediately adjacent.
Modeling CD11b/CD18 ectodomain on the membrane
We analyzed our FLIM data by systematically evaluating
atomic models to determine the relative orientation of the integrin
ectodomain to the membrane plane. The lipid bilayer is modeled
as a plane (see methods), with the FLIM distance taken as the
shortest distance from the centroid to any point on the plane.
Orientation of the integrin on the lipid bilayer requires specifying
two angles, the angle between the long axis of Calf-1/Calf-2
domains and the membrane plane (the tilt angle, H, being 0u or
90u when the long axis of Calf-2 is either flush with or
perpendicular to the membrane, respectively) and the direction
of the tilt angle (W). With only a single FLIM distance
measurement, a large number of combinations of the two angles
may be found. Our measured mean FLIM distance of 71A ˚
between Fab107 and the lipid headgroups provided the initial
constraint. To determine the angles that satisfy this distance, an
atomic model of the integrin/Fab107 complex generated by the fit
to the EM data (Figure 3B) is rotated along all available angles and
the resulting distance between the Fab107 centroid and the
membrane plane measured at each point. There is not as yet an X-
ray structure of any intact integrin, and this has compelled our
modeling to be performed with ectodomain structures instead, all
of which adopt similar bent conformations, where the legs are bent
back to position the membrane junctional regions proximal to the
head domain. Current structural investigations on full-length
integrins lack atomic (or even near-atomic) resolution but do agree
that the full-length structure of the inactive conformation is also
compact, with its ectodomain likely bent [28,29]. As a result, our
ectodomain model was rotated through a full 360u in W and 180u
in H, which allows the leg domains to vary from completely
vertical to lying flat on the surface of the membrane to being
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clashes with the membrane, the membrane was modeled as a
simple plane in x-y, and excluding models where any atom dipped
below it. A 5u search for both angles generated a total of 114
possible orientations where the CD11b/CD18-Fab107 complex
would not clash with the membrane (Figure 5A,B). Applying the
further FLIM distance constraint of 71A ˚ between Fab107 and
membrane plane further reduced the number of orientations to
eight. These solutions possess a range of tilt angles (H)o f5 0 u to
60u and an average angle of 52.5u. To check our ectodomain
model, we considered the CD11c/CD18 X-ray structure, which
does not fit well with our EM ectodomain structure but which
might represent the intact full-length structure. This latter model,
generated by aligning the aA domains in the CD11c/CD18 and
CD11bA/Fab107 X-ray structures, failed to produce any orien-
tation that simultaneously satisfied the membrane clash and FLIM
distance criteria.
In this report, we have used electron microscopy and 3D image
reconstruction to determine the 3D structure of inactive CD11b/
CD18 ectodomain and position its ligand-binding CD11bA
domain within the integrin head. We have also utilized FLIM,
using the structurally defined reporter of the MIDAS face,
Fab107, to precisely define the relation of the CD11bA MIDAS
face to the plasma membrane in live cells. The measured distance
suggests that the MIDAS face in the cellular integrin is not
occluded by the plasma membrane as commonly depicted, but is
accessible to soluble macromolecular ligands, while the EM
reconstruction indicates that this would be true for this integrin in
its bent conformation.
Previous crystal structure work on the related integrin CD11c/
CD18 ectodomain indicated that the connection between the
ligand-binding aA (CD11cA) domain and the Propeller domains is
highly flexible [17]: three of the four molecules within the unit cell
in the X-ray structure possessed no density for CD11cA, while the
visible CD11cA are stabilized with crystal contacts from symme-
try-related molecules (Figure 3E,F). In contrast, our 3D EM
structure reveals that CD11bA is fairly well constrained to a small
range of conformations in the ectodomain in solution. CD11bA is
clearly visible in all of the reference-free class averages (Figure 1A),
consistent with a previous 2D EM study in the related CD11c/
CD18 ectodomain [30], whereas if the domain had been very
flexible, we would expect the density to be averaged out. It is also
unlikely that the differences observed between the two b2 integrins
relate to the allosteric effect of the introduced disulfide bond that
covalently links the a/b heterodimer, as this bond was present at
the identical position in both integrin ectodomains.
The EM averages of the CD11b/CD18-Fab107 complex
further restricted the range of possible orientations of CD11bA,
as evidenced by the clear and unambiguous density for the Fab in
the averages (Figure 3). And in contrast with the X-ray structure of
CD11c/CD18 ectodomain, CD11bA has been rotated on axis
about 35u in our EM structure (Figure 3). One interpretation for
these differences is that aA is more flexible in integrin CD11c
when compared to that of CD11b. However, the N- and C-
terminal aminoacid sequences linking aA to the respective CD11c
and CD11b Propeller domains are highly conserved (The N-
terminal sequence starting at residue 127 is PRQ in CD11c vs.
PQE starting at residue 129 in CD11b while the C-terminal
linker is 319IEGTQTGSSSSFEHEMS vs. 317IEGTETTSSSS-
FELEMA for CD11c and CD11b, respectively). An alternative
explanation is that the difference might be due to unfavorable
crystal contacts in the CD11c/CD18 ectodomain crystal structure
Figure 4. FLIM lifetimes of the Alexa488 donor fluorescence in
the presence and absence of the acceptor FM. A) Representative
Alexa488 fluorescence intensity and lifetime images. The panel shows
examples of data collected in the absence (left, WT 488) and presence
of the acceptor FM (right, WT 488+FM). The pseudocolor scale is shown
at the bottom. B, histogram of measured Alexa488 lifetimes generated
by integrating lifetime measurements for individual cells. The histogram
bars show the number of cells in 50 ps bins for Alexa488 in the absence
(blue) and presence (red) of the acceptor FM. The average and standard
deviation were generated by fitting the histogram to a single Gaussian
function (shown as a solid line).
doi:10.1371/journal.pone.0057951.g004
Figure 5. Modeling of the relative membrane orientation of
CD11b/CD18 by combining the FLIM and EM data. A) A display
of the allowed orientations of the integrin ectodomain. To determine
the allowed orientations, the protein is first rotated in the membrane
plane and subsequently rotated down. For each rotation pair, the
model is evaluated for clashes with the membrane. Shown in magenta
are the centroids for Fab107 for all of the resulting angles. For
illustration purposes, the integrin a- (blue), b- (red) subunits and Fab107
(green) chains are displayed as a ribbon diagram for one of the resulting
orientations. A section of a model DMPC membrane is shown as a wire
diagram. The model of the CD11b/CD18 ectodomain is taken from the
fit to the EM map. The distance of the centroid for the displayed model
is compatible with the measured FLIM distance. B) The same view as in
(A) but rotated in the y-axis by 45u. The a/b TM domains (modeled after
the NMR structure of aIIbb3 TM domains [46]) are displayed for
illustrative purposes only, and were not used in the orientation search.
doi:10.1371/journal.pone.0057951.g005
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and Conclusions(Figure 3E,F), stabilizing the CD11cA domain in a non-physiologic
orientation. The position of CD11bA as defined by the 3D EM
structure would allow for an unobstructed movement for the 10A ˚-
displacement of its c-terminal helix 7 associated with ligand-
occupancy [31], permitting Glu320 at the end helix 7 to engage
the bA domain MIDAS site [15], without additional rotations of
the aA domain, thus allowing for the ligand-associated protein
movements with only relatively small changes in this domain.
As our acceptor fluorophore is confined to the outer leaflet of
the plasma membrane, the FLIM lifetime measurements conduct-
ed in the presence of Ca
2+, provide an accurate distance
separating the macromolecular ligand mimetic Fab107 and the
membrane. The mean separation between the CD11bA-bound
Fab107 and the cell membrane in inactive full-length CD11b/
CD18 was approximately 70A ˚ (Figure 5A,B). This is not consistent
with an extended model for the integrin [32], where the distance
from the membrane to CD11bA would be closer to 160A ˚, and
suggests a much more compact conformation for the inactive state.
However, the ,70A ˚ distance is significantly greater than
conventional models of the inactive membrane-bound integrin
that rely on depicting the bent configuration of the ectodomain
with the long axis of Calf-1/Calf-2 domains aligned perpendicular
to the membrane plane [29]. Indeed, the ,70A ˚ distance places the
MIDAS face of CD11bA well clear of the membrane, where it is
able to engage macromolecular ligands in solution.
The FLIM distance of the anti-aV mAb Fab17E6 from the
plasma membrane for the aA-lacking integrin aVb3 was
previously determined, which yielded a tilt angle of ,30u [4].
Applying the same nonbiased approach reported here through
exploration of the full Euler angle space possible between the X-
ray structures and a plane representing the membrane (Figure S2),
yielded a range of tilt angles between 30u to 45u. Of interest is that
the direction of the tilt (W) was remarkably homogenous for both
the aA-containing CD11b/CD18 and lacking (aVb3) integrins,
with angles (based on our initial orientation) of 323.6u (S.D. 14.6u)
for CD11b/CD18 and 322.2u (S.D. 17.1u) for aVb3 (this angle
determines which face of the integrin is tilting towards the
membrane). The virtual identity for the determined tilt ranges
indicates continuity in tilting of integrins, suggesting that there is
likely to be some structural conservation in the short a/b linker
regions with the transmembrane domains such that the link will
always ‘hinge’ in the same direction. The two integrins do,
however, have different tilt angles (H): a mean 34.4u (S.D. 4.2u) tilt
for aVb3 but a 52.5u (S.D. 3.8u) tilt for the aA-containing CD11b/
CD18 (Figure S3). Despite the rigorous exploration of the full
Euler angle space, none of the allowed orientations will
simultaneously satisfy both FLIM distance constraints. This might
well represent a real difference between the structures of b2 and b
3 integrins, where the aA-containing b2 integrins would adopt a
more obtuse angle relative to the membrane normal. Such an
angle would position the aA MIDAS face somewhat more
elevated above the surface of the membrane, which might in turn
facilitate its binding to macromolecular ligands.
Our current model of an inactive full-length bent integrin
embedded a lipid bilayer, if extended to other integrins, would
allow unhindered access of Fab fragments of a number of mAbs
(with known crystal structures complexed with extracellular
integrin domains [3,33–35]) to the cellular integrin (Figure S4).
The sole exception is the mAb SG/19, which binds to inactive
a5b1 head [36], where the bound Fab would clash with the
membrane surface in our full-length integrin model (Figure S4).
Binding of this Fab would be allowed if the tilt angle is increased to
between 75–80u, although it would no longer be possible to satisfy
the FLIM distances for Fab 107 (Figure 5) or for 17E6 Fab (Figure
S2). It might also be, as the authors suggest, that the inactive a5b1
ectodomain may not adopt the compact bent conformation found
in the other ectodomains with determined crystal or EM
structures.
The present data have some bearing on existing models of
inside-out integrin activation. In the absence of a crystal structure
of a full-length inactive integrin, its Calf-1/Calf-2 domains were
empirically positioned orthogonal to the cell membrane in the
bent state (see for example [29]), an orientation that sterically
blocks the bA MIDAS in the aA-lacking integrin subgroup by the
plasma membrane, and places the extra aA domain in the aA-
containing subgroup at or within the lipid bilayer. This depiction
provided the rationale for the proposed requirement for an inside-
out activation-triggered linearity at the genu as a prerequisite for
access of extrinsic ligands to the integrin (the switchblade model)
[29,37]. In favor is a negative-stain 2D EM study of aIIbb3
embedded in small bilayer ‘minidiscs’ [29], which found that in the
presence of talin and ligand, 22% of the lipid-reconstituted
unliganded aIIbb3 assumed an extended form [37]. However, the
presence of ligand in the sample leaves open the possibility that the
extended state is the outcome of conformational memory induced
by the prior encounter of the integrin with ligand [38–40]. The
data presented in this paper using a combination of biophysical
methods suggest that the ligand binding site is accessible to
extracellular ligands in the bent conformation, providing structure-
based support for a number of biochemical studies showing that
genu-linearity does not necessarily antecede ligand binding
[9,20,41–44] at least in b2 and b3 integrins as initially proposed
by the bTD-centric deadbolt model [45].
Supporting Information
Figure S1 Binding of mAb107 to the wild-type and I316G
mutant cellular CD11b/CD18, expressed as a percent-
age of binding of the heterodimer-specific mAb IB4.
Histograms (mean+SD, n=3) showing binding of mAb 107 to
wild-type or I316G CD11b/CD18 stably expressed on K562 in
presence of 1 mM Ca
2+ or 5 mM Mg
2+/1 mM EGTA. mAb 107
recognizes either integrin in 1 mM Ca
2+ (low affinity) but not in
Mg
2+/EGTA (high affinity) state.
(TIF)
Figure S2 A systematic orientation search of aVb3
ectodomain relative to membrane, employing previous-
ly published FLIM data (see text). A and B, integrin a- (blue),
b-(red) subunits and Fab17E6 (yellow) subunits are displayed as a
ribbon diagram. A section of a model DMPC membrane is shown
as a wire diagram. The ectodomain is sequentially rotated
identically to that in Figure 5A,B. The model is again evaluated
for clashes with the membrane for each orientation. Shown in
cyan are the centroids for Fab17E6 for all of the allowed
orientations. Only one of the allowed orientations is displayed.
The centroid for the model is indicated by the cyan line, which
connects the centroid to the membrane plane. The distance
indicated is compatible with the measured FLIM distance. The a/
b TM domains (modeled after the NMR structure of aIIbb3TM
domains) are displayed for illustrative purposes only, and were not
used in the orientation search. A section of a model DMPC
membrane is shown as a wire diagram.
(TIF)
Figure S3 Plot of the allowed Euler angles for full-length
integrin aVb3 bound to Fab17E6 (open circles) and full
length CD11b/CD18 bound to Fab107 (closed circles).
Angles represent the variation at 5 intervals of the ectodomain
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angle pair, the model was checked for steric clashes with the
modeled membrane and that the distance of the respective Fab
centroid to the membrane corresponded to the value determined
by FLIM. Although the orientations do not overlap, they occupy a
fairly narrow zone in space.
(TIF)
Figure S4 Binding of mAb Fab fragments directed
against four different aA-lacking integrins as defined
by X-Ray crystal structure determination of integrin-
Fab complexes (see text). Ribbon diagrams of aVb3
ectodomain (a- and b-subunits in blue and red, respectively)
complexed to 17E6 Fab (yellow); aIIbb3 headpiece/10E5 Fab
(gray) complex (2vdn.pdb); a4b7 headpiece/ACT-1 Fab (brown)
complex (3v4p.pdb), and a5b1 headpiece/SG/19 Fab (green)
complex. The ADMIDAS metal ion (cyan sphere), and Propeller
and a-genu metal ions (orange spheres) in aVb3 ectodomain are
shown. The diagram was generated by superposing structure of
the Propeller domain from the integrin in each complex onto that
of the aV structure, using Matchmaker in Chimera. The a/b TM
domains (modeled after the NMR structure of aIIbb3T M
domains) are displayed for illustrative purposes only. A section of a
model DMPC membrane is shown as a wire diagram.
(TIF)
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